Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies

1. FERLAY J., SOERJOMATARAM, I., ERVIK, M., DIKSHIT, R., ESER, S., MATHERS, C., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Journal. 2013.Search in Google Scholar

2. MCGLYNN K., TSAO, L., HSING, A., DEVESA, S. and FRAUMENI, J. International trends and patterns of primary liver cancer. Int J Cancer. 2001; 94:290-6.10.1002/ijc.145611668511Search in Google Scholar

3. SOMOVA A., GOLOSOVA, T., MARGOLINA, A. and BAGRIANTSEVA, S. The serodiagnosis of viral hepatitis C and B in different population groups. Voprosy Virusologii (Questions in Virology). 1992; 37:191-3.Search in Google Scholar

4. KOSTRITSA S., KUZIN, S., KHUKHLOVICH, P., SHAKHGIL’DIAN, I., DOROSHENKO, N., BLINOV, V., et al. The detection of antibodies to the hepatitis C virus and to HBsAg in donors with viral hepatitis and cancerous diseases in the Republic of Moldova. Voprosy Virusologii (Questions in Virology). 1994; 39:93-4.Search in Google Scholar

5. STEPANOV G., BONDARENKO, M. and LAROVOĬ, P. Role of the instrument transmission factor in the epidemiology of viral hepatitis. II. Methods, materials, chief results. Zh Mikrobiol Epidemiol Immunobiol. 1977; 4:133-9.Search in Google Scholar

6. NEGRESKU G., IASHINA, T., BURKOV, A. and FAVOROV, M. The clinical picture and outcome of acute delta infection. Klin Med (Mosk). 1992; 70:80-4.Search in Google Scholar

7. L’VOV D., MISHIRO, S., SELIVANOV, N., SAMOKHVALOV, E., SHAKHGIL’DIAN, I., STAKHANOVA, V., et al. Prevalence of genotypes of the hepatitis C virus, circulating in northwestern and central parts of Russia. Voprosy Virusologii (Questions in Virology). 1995; 40:251-3.Search in Google Scholar

8. WORLD HEALTH ORGANIZATION. Global status report on alcohol and health 2014.Search in Google Scholar

9. LACHENMEIER D., SCHOEBERL, K., KANTERES, F., KUBALLA, T., SOHNIUS, E., REHM, J., et al. Is contaminated unrecorded alcohol a health problem in the European Union? A review of existing and methodological outline for future studies. Addiction. 2011; 106:Suppl 1:20-30.10.1111/j.1360-0443.2010.03322.x21324018Search in Google Scholar

10. WHO W.H.O. Age-standardized death rates of liver cirrhosis. 2017.Search in Google Scholar

11. TURCANU G., DOMENTE, S., BUGA, M. and RICHARDSON, E. Republic of Moldova health system review. 2012; 14.Search in Google Scholar

12. TANASE A., MARCHIO, A., DUMITRASCU, T., DIMA, S., HERLEA, V., OPRISAN, G., et al. Mutation Spectrum of Hepatocellular Carcinoma from Eastern-European Patients betrays the Impact of a complex Exposome. J Exp Sci Env Epidemiol. 2014; 25:256-63.10.1038/jes.2014.1624736102Search in Google Scholar

13. SCHIAVON L., SCHIAVON, J., CARVALHO FILHO, R., SAMPAIO, J., LANZONI, V., SILVA, A., et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology. 2007; 46:307-14.10.1002/hep.2168117634962Search in Google Scholar

14. VALLET PICHARD A., MALLET, V., NALPAS, B., VERKARRE, V., NALPAS, A., DHALLUIN VENIER, V., et al. FIB 4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46:32-6.10.1002/hep.2166917567829Search in Google Scholar

15. KINOSHITA A., ONODA, H., FUSHIYA, N., KOIKE, K., NISHINO, H. and TAJIRI, H. Staging systems for hepatocellular carcinoma: current status and future perspectives. World J Hepatol. 2015; 7:406.10.4254/wjh.v7.i3.406438116625848467Search in Google Scholar

16. JOHNSON P., BERHANE, S., KAGEBAYASHI, C., SATOMURA, S., TENG, M., REEVES, H., et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade. J Clin Oncol. 2014; 33:550-8.10.1200/JCO.2014.57.9151432225825512453Search in Google Scholar

17. DE MARTEL C., MAUCORT-BOULCH, D., PLUMMER, M. and FRANCESCHI, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015; 62:1190-200.10.1002/hep.27969501926126146815Search in Google Scholar

18. RAZA S., CLIFFORD, G. and FRANCESCHI, S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 2007; 96:1127-34.10.1038/sj.bjc.6603649236011717406349Search in Google Scholar

19. PERZ J., ARMSTRONG, G., FARRINGTON, L., HUTIN, Y. and BELL, B. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45:529-38.10.1016/j.jhep.2006.05.01316879891Search in Google Scholar

20. SHAKHGIL’DIAN I., FARBER, N., KUZIN, S., CHESHIK, S., DROBENIUK, Z., MIKHAILOV, M., et al. Perinatal infection with hepatitis B virus and the problem of its specific prevention. Vestn Akad Med Nauk SSSR (Ann Russian Acad Med Sci). 1990; 7:29-32.Search in Google Scholar

21. VOICULESCU M., ILIESCU, L., IONESCU, C., MICU, L., ISMAIL, G., ZILISTEANU, D., et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis. 2010; 19:43-8.Search in Google Scholar

22. BLACHIER M., LELEU, H., PECK-RADOSAVLJEVIC, M., VALLA, D. and ROUDOT-THORAVAL, F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013; 58:593-608.10.1016/j.jhep.2012.12.00523419824Search in Google Scholar

23. GRIGORIE R., ALEXANDRESCU, S., SMIRA, G., IONESCU, M., HREHOREŢ, D., BRAŞOVEANU, V., et al. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center. Chirurgia (Bucur). 2017; 112:289-300.10.21614/chirurgia.112.3.28928675364Search in Google Scholar

24. HEIDRICH B., DETERDING, K., TILLMANN, H., RAUPACH, R., MANNS, M. and WEDEMEYER, H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat. 2009; 16:883-94.10.1111/j.1365-2893.2009.01144.x19566789Search in Google Scholar

25. WEDEMEYER H. and MANNS, M. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7:31-40.10.1038/nrgastro.2009.20520051970Search in Google Scholar

26. WRANKE A., PINHEIRO BORZACOV, L., PARANA, R., LOBATO, C., HAMID, S., CEAUSU, E., et al. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2017; 38:842-50.10.1111/liv.1360428963781Search in Google Scholar

27. NEGRO F. Hepatitis D Virus Coinfection and Superinfection. Cold Spring Harb Perspect Med. 2014; 4:a021550.10.1101/cshperspect.a021550420870725368018Search in Google Scholar

28. TSATSRALT-OD B., TAKAHASHI, M., NISHIZAWA, T., ENDO, K., INOUE, J. and OKAMOTO, H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol. 2005; 77:491-9.10.1002/jmv.2048216254981Search in Google Scholar

29. DEGERTEKIN H., YALÇIN, K. and YAKUT, M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies. Turk J Gastroenterol. 2006; 17:25-34.Search in Google Scholar

30. AMOUGOU ATSAMA M., NOAH NOAH, D., FEWOU MOUNDIPA, P., PINEAU, P. and NJOUOM, R. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa. BMC Infect Dis. 2016; 16:647.10.1186/s12879-016-1992-2510018427821080Search in Google Scholar